FDA Considers Whether To OK Pfizer Vaccine For Children
View Mobile Site
Save Email Print
FDA Considers Whether To OK Pfizer Vaccine For Children
The FDA is considering whether to approve an updated version of a bestselling anti-infection vaccine for children.
Font Size:

WASHINGTON (November 16, 2009)--The U.S. Food and Drug Administration is considering whether to approve an updated version of Pfizer's bestselling anti-infection vaccine for children, despite company studies that failed to meet certain goals.

The Prevnar 13 vaccine reduces risk of infection by 13 varieties of pneumococcal disease, which causes ear infections, meningitis and pneumonia.

The new version of the vaccine protects against six more varieties of the disease, but FDA reviewers say in online documents that company studies failed to meet effectiveness goals for three types of pneumococcal disease.

The FDA will ask a panel of outside vaccine experts to weigh in on the results at a meeting Wednesday.

The agency is not required to follow the group's advice, though it usually does.

FDA Web Site

Spotlight on Health
KWTX.com Features
Double Dollar Deals
Half Price Deals at Central Texas restaurants and businesses. A new deal every Thursday at 7:00am.
Boss of the Month
Who is Central Texas’ best boss? Nominate your supervisor for Boss of the Month!
Golden Apple
Your chance to nominate an outstanding teacher. Find out how they are making a difference in classrooms.
Emily Wants to Know
Emily Matthews' inquisitive look at life in Central Texas.
Army Way
Learn all about the symbols, traditions, and customs of the US Army.
For Your Health